Association between maternal pregestational diabetes mellitus and spina bifida: A population-based case-control study, Finland, 2000-2014

被引:7
作者
Mowla, Sanjida [1 ]
Gissler, Mika [2 ,3 ,4 ]
Raisanen, Sari [5 ]
Kancherla, Vijaya [1 ]
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, 1518 Clifton Rd NE, Atlanta, GA 30322 USA
[2] Informat Serv Dept, Helsinki, Finland
[3] Karolinska Inst, THL Finnish Inst Hlth & Welf, Stockholm, Sweden
[4] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden
[5] Tampere Univ Appl Sci, Sch Hlth Care & Social Serv, Tampere, Finland
来源
BIRTH DEFECTS RESEARCH | 2020年 / 112卷 / 02期
关键词
diabetes mellitus; neural tube defects; pregnancy; risk factors; spina bifida; NEURAL-TUBE DEFECTS; NEW-YORK-STATE; BIRTH-DEFECTS; DATA QUALITY; OBESITY; WOMEN; RISK; TERATOGENESIS; EMBRYOPATHY; PREVALENCE;
D O I
10.1002/bdr2.1624
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Maternal pregestational diabetes mellitus (PGDM) is a known risk factor for neural tube defects. We examined the association between maternal PGDM and spina bifida in the offspring using PGDM status from medical records in Finland. Methods We conducted a nationally representative, multiregistry, population-based case-control study in Finland. Cases were included if they were live or stillborn infants and diagnosed with spina bifida and delivered between years 2000 and 2014 in Finland. Controls were Finnish infants without spina bifida or other major structural birth defects and delivered during the same time period as cases. Clinical and demographic data were obtained by linking multiple national health registers and census. Crude and adjusted odds ratios (ORs) and 95% confidence intervals (CI) for PGDM were estimated using logistic regression analysis. Interaction by maternal obesity was examined. Results Our study included 181 spina bifida cases (61% isolated) and 876,672 controls. Overall, 2.2% percent of all case, and 0.5% of control mothers, had PGDM during pregnancy. Maternal PGDM was significantly associated with an increased odds of spina bifida (adjusted OR 4.35; 95% CI 1.37, 13.82). A similar association was found in our subanalysis on isolated spina bifida cases (adjusted OR 4.41; 95% CI 1.07, 18.24). There was no significant interaction by maternal obesity. Conclusions Maternal PGDM was positively associated with spina bifida in Finland, and maternal obesity did not modify this effect. We lacked information on maternal PGDM for electively terminated and spontaneously aborted cases; results should be interpreted with caution.
引用
收藏
页码:186 / 195
页数:10
相关论文
共 45 条
  • [1] Congenital Abnormalities in Newborns of Women with Pregestational Diabetes: A Time-Trend Analysis, 1994 to 2009
    Agha, Mohammad M.
    Glazier, Richard H.
    Moineddin, Rahim
    Booth, Gillian
    [J]. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2016, 106 (10) : 831 - 839
  • [2] Proportion of neural tube defects attributable to known risk factors
    Agopian, A. J.
    Tinker, Sarah C.
    Lupo, Philip J.
    Canfield, Mark A.
    Mitchell, Laura E.
    [J]. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2013, 97 (01) : 42 - 46
  • [3] Teratogenicity Associated With Pre-Existing and Gestational Diabetes
    Allen, Victoria M.
    Armson, B. Anthony
    Wilson, R. Douglas
    Blight, Claire
    Gagnon, Alain
    Johnson, Jo-Ann
    Langlois, Sylvie
    Summers, Anne
    Wyatt, Philip
    Farine, Dan
    Crane, Joan
    Delisle, Marie-France
    Keenan-Lindsay, Lisa
    Morin, Valerie
    Schneider, Carol Ellison
    Van Aerde, John
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2007, 29 (11) : 927 - 934
  • [4] Maternal obesity, gestational diabetes, and central nervous system birth defects
    Anderson, JL
    Waller, DK
    Canfield, MA
    Shaw, GM
    Watkins, ML
    Werler, MM
    [J]. EPIDEMIOLOGY, 2005, 16 (01) : 87 - 92
  • [5] [Anonymous], 2019, CONG AN
  • [6] [Anonymous], 2018, OBSTET GYNECOL
  • [7] Arbour L, 2009, INT J CIRCUMPOL HEAL, V68, P443
  • [8] Hyperglycemia induces embryopathy, even in the absence of systemic maternal diabetes: An in vivo test of the fuel mediated teratogenesis hypothesis
    Baack, Michelle L.
    Wang, Chunlin
    Hu, Shanming
    Segar, Jeffrey L.
    Norris, Andrew W.
    [J]. REPRODUCTIVE TOXICOLOGY, 2014, 46 : 129 - 136
  • [9] BECERRA JE, 1990, PEDIATRICS, V85, P1
  • [10] BLENCOWE H, 2015, ANN NY ACAD SCI, V1414, P31